Nanalysis Scientific Corp. NSCIF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 68.62% | -2.54% | 90.18% | 9.65% | -5.20% |
| Total Depreciation and Amortization | -15.35% | -68.98% | 118.53% | -74.42% | -9.93% |
| Total Amortization of Deferred Charges | -- | -- | -89.90% | -- | -- |
| Total Other Non-Cash Items | 112.87% | -2.07% | -89.60% | -81.25% | -63.57% |
| Change in Net Operating Assets | 63.32% | -110.40% | 366.22% | 116.42% | -202.99% |
| Cash from Operations | 146.02% | -105.12% | 149.40% | 5.28% | -246.99% |
| Capital Expenditure | 83.94% | 28.19% | -- | -493.18% | -8,885.71% |
| Sale of Property, Plant, and Equipment | -- | 160.00% | -73.06% | -96.17% | 83.59% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 123.40% | 66.77% | -15.08% | 25.96% | 30.76% |
| Cash from Investing | 118.26% | 67.10% | -98.26% | 13.91% | 21.05% |
| Total Debt Issued | -- | -- | 21.97% | -22.64% | -- |
| Total Debt Repaid | 14.78% | -6.84% | -119.63% | 103.30% | -26.24% |
| Issuance of Common Stock | -86.38% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 68.44% | 25.22% | -10.81% | 9.52% | 3.66% |
| Cash from Financing | -162.19% | 20.13% | 76.24% | 511.38% | 234.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.41% | -279.58% | 139.31% | 107.23% | 36.79% |